Foresite Capital Management V, LLC
Q3 2026 13F-HR Holdings
Net value change ($000)
-73,054
(-20.2%)
New positions
1
Sold out positions
1
Turnover %
22.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Latigo Biotherapeutics, Inc. | 59,502 | NEW |
| NRIX | 4,448 | 69.2% |
| Odyssey Therapeutics, Inc. | 2,870 | 21.5% |
| HIMS | 735 | 2.9% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|